BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3780839)

  • 1. Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency.
    Dodion L; Willems JL
    Eur J Clin Pharmacol; 1986; 31 Suppl():49-51. PubMed ID: 3780839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of torasemide and its metabolites in end-stage renal disease.
    Krämer BK; Schwab A; Braun N; Strutz F; Müller GA; Risler T
    Eur J Clin Pharmacol; 1994; 47(2):157-9. PubMed ID: 7859803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and metabolism of torasemide in man.
    Neugebauer G; Besenfelder E; von Möllendorff E
    Arzneimittelforschung; 1988 Jan; 38(1A):164-6. PubMed ID: 3370063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the pharmacokinetics and diuretic effects of two loop diuretics, torasemide and furosemide, in normal volunteers.
    Dodion L; Ambroes Y; Lameire N
    Eur J Clin Pharmacol; 1986; 31 Suppl():21-7. PubMed ID: 3780837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of torasemide in humans: an overview of its diuretic effect.
    Lesne M; Clerckx-Braun F; Duhoux P; van Ypersele de Strihou C
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):382-7. PubMed ID: 7118326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of torasemide in health and disease.
    Brater DC
    J Cardiovasc Pharmacol; 1993; 22 Suppl 3():S24-31. PubMed ID: 7506334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of haemodialysis and haemofiltration on the clearance of torasemide in renal failure.
    Loute G; Adam A; Ers P; Heremans C; Willems B
    Eur J Clin Pharmacol; 1986; 31 Suppl():53-5. PubMed ID: 3780840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects.
    Ambroes Y; Ronflette I; Dodion L
    Eur J Clin Pharmacol; 1986; 31 Suppl():1-7. PubMed ID: 3780835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics and pharmacodynamics of torasemide.
    Knauf H; Mutschler E
    Clin Pharmacokinet; 1998 Jan; 34(1):1-24. PubMed ID: 9474471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretic effect and pharmacokinetics of tizolemide in subjects with normal and decreased renal function.
    Beermann B; Odlind B; Wibell L
    Clin Nephrol; 1983 Mar; 19(3):124-31. PubMed ID: 6839561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacology of torasemide, a new loop diuretic.
    Brater DC; Leinfelder J; Anderson SA
    Clin Pharmacol Ther; 1987 Aug; 42(2):187-92. PubMed ID: 3608350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency.
    Gehr TW; Rudy DW; Matzke GR; Kramer WG; Sica DA; Brater DC
    Clin Pharmacol Ther; 1994 Jul; 56(1):31-8. PubMed ID: 8033492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of indomethacin to impair the diuretic and natriuretic effects of the loop diuretic torasemide in healthy volunteers.
    van Ganse E; Douchamps J; Deger F; Staroukine M; Verniory A; Herchuelz A
    Eur J Clin Pharmacol; 1986; 31 Suppl():43-7. PubMed ID: 3536531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of torasemide in patients with chronic renal insufficiency--preliminary evaluation.
    Brater DC; Rudy DR; Voelker JR; Greene PK; Gehr T; Sica DA
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():69-73. PubMed ID: 8435379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of the loop diuretic torasemide to improve renal function of hypoxemic vasomotor nephropathy in the newborn rabbit.
    Dubourg L; Drukker A; Guignard JP
    Pediatr Res; 2000 Apr; 47(4 Pt 1):504-8. PubMed ID: 10759158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers.
    Lambe R; Kennedy O; Kenny M; Darragh A
    Eur J Clin Pharmacol; 1986; 31 Suppl():9-14. PubMed ID: 3780841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the loop diuretic piretanide in renal failure.
    Walter U; Röckel A; Lahn W; Heidland A; Heptner W
    Eur J Clin Pharmacol; 1985; 29(3):337-43. PubMed ID: 4076330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a new diuretic, torasemide, in man.
    Lesne M; Clerckx-Braun F; Duhoux F; van Ypersele C
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):322-5. PubMed ID: 7224731
    [No Abstract]   [Full Text] [Related]  

  • 19. Torasemide, a new potent diuretic. Double-blind comparison with furosemide.
    Broekhuysen J; Deger F; Douchamps J; Ducarne H; Herchuelz A
    Eur J Clin Pharmacol; 1986; 31 Suppl():29-34. PubMed ID: 3536530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of high doses of piretanide in moderate to severe renal failure.
    Marone C; Reubi FC; Perisic M; Lahn W
    Eur J Clin Pharmacol; 1984; 27(5):589-93. PubMed ID: 6519164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.